MedPath

Psychobiology in Inflammatory Bowel Disease(IBD)

Not Applicable
Completed
Conditions
Inflammatory Bowel Disease
Registration Number
NCT00248742
Lead Sponsor
Oslo University Hospital
Brief Summary

Patients with ulcerous colitis and Crohn's disease, age 18-60, with a relapse within the last 18 months and an activity index ≥4, with a long time stress level ≥60 on the perceived stress questionnaire (PSQ) were randomized to a stress management intervention program or treatment as usual and followed up for 18 months.

Detailed Description

The study includes distressed patients with ulcerous colitis and Crohn's disease with relapse or enduring activity last 18 months and an simple activity index ≥4, on stable medication last 4 weeks. All patients were followed by a gastroenterologist at baseline, 3, 6, 12 and 18 months follow up and a psychiatrist or clinical psychologist at 18 months. Half of the patients received additional psychosocial intervention (education, relaxation, supportive psychotherapy with stress management). Assessments include gastrointestinal assessments; blood tests; psychiatric evaluations and psychometric evaluations.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
114
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Improvement in activity index.18 months
Secondary Outcome Measures
NameTimeMethod
Reduction of inflammatory parameters.18 months
Reduction in number of relapses.18 months
Quality of life improvement18 months
Psychobiological factors related to improvement18 months

Trial Locations

Locations (1)

RRHF

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath